Association of metabolic syndrome and IgA nephropathy

Journal of Clinical Pathology

Volumn 63, Issue 8, 2010, Pages 697-701

  Wang, Liping ^a   Zhang, Yong ^a   Chen, Shanyuan ^b   Chen, Jian ^a   Zhuang, Yongze ^a   Chen, Jinhua ^a  

^a Dongfang Hospital   (China)

^b College of Traditional Chinese Medicine of Fujian ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGE; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADULT; BIOLOGICAL MARKERS; CREATININE; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 77955733561     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.074278     Document Type: Article

References (24)

1. Lim HS, Patel JV, Lip GY. Metabolic syndrome: a definition in progress. Circulation 2004;110:35.
2. Eckle RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
3. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-304.
4. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004;140:167-74.
5. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephro1 2005;16:2134-40. (Pubitemid 41716445)
6. Zhang R, Liao J, Morse S, et al. Kidney disease and the metabolic syndrome. Am J Med Sci 2005;330:319-25.
7. Chen J, Gu D, Chen CS, et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007;22:1100-6. (Pubitemid 46523424)
8. Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 2004;66:920-3.
9. Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal diseases. Hum Pathol 1982;13:314-22.
10. Katafuchi R, Kiyoshi Y, Oh Y. Glomerular score as a prognosticatorin IgA nephropathy:its usefulness and limitation. Clin Nephrol 1998;1:1-8. (Pubitemid 28043359)
11. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987;245:709-27. (Pubitemid 18047151)
12. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988;12:340-7.
13. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000;36:227-37. (Pubitemid 30485830)
14. Bartosik LP, Lajoie G, Sugar L, et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001;38:728-35.
15. Muntner LG, Coresh J, Smith JC, et al. Plasma and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000;58:293-301. (Pubitemid 30429874)
16. Hirano H, Yamada Y, Otani H, et al. Evaluation of serum lipid abnormalities in chronic nephritis. Kidney Int Suppl 1999;71:S147-9.
17. Jie W, Xiangmei C, Yuansheng X, et al. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant 2005;20:719-27.
18. Myllyma J, Honkanen T, Syrja J, et al. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant 2005;20:89-95. (Pubitemid 40207612)
19. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14:469-77. (Pubitemid 36150872)
20. Ryu S, Chang Y, Woo HY, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 2009;53:59-69.
21. Ross WR, McGill JB. Epidemiology of obesity and chronic kidney disease. Adv Chronic Kidney Dis 2006;13:325-35.
22. Nakamura T, Fujikura Y, Suga N, et al. An IgA nephropathy case with highly reduced urinary protein concomitant with reduced obesity. Nippon Jinzo Gakkai Shi 2006;48:675-9. (Pubitemid 44787669)
23. Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009;76:534-45.
24. Roberts ISD, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: pathological definitions, correlations, and reproducibility. Kidney Int 2009;76:546-56.